Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Homo sapiens | CREB binding protein | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2285 | 0.2705 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.2285 | 0.2285 |
Echinococcus granulosus | proprotein convertase subtilisin:kexin type 5 | 0.0089 | 0.2843 | 0.4865 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0035 | 0.0398 | 0.1032 |
Schistosoma mansoni | subfamily S8B non-peptidase homologue (S08 family) | 0.0035 | 0.0398 | 0.0351 |
Brugia malayi | celfurPC protein | 0.0118 | 0.4151 | 0.4151 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0089 | 0.2843 | 1 |
Schistosoma mansoni | CREB-binding protein 1 (SmCBP1) | 0.0122 | 0.4351 | 0.528 |
Schistosoma mansoni | furin-1 (S08 family) | 0.0064 | 0.1706 | 0.1982 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0035 | 0.0398 | 0.1032 |
Brugia malayi | TAZ zinc finger family protein | 0.0122 | 0.4351 | 0.4351 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0026 | 0 | 0.5 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.2285 | 0.2285 |
Schistosoma mansoni | hypothetical protein | 0.0207 | 0.8136 | 1 |
Echinococcus granulosus | CREB binding protein | 0.0075 | 0.224 | 0.3666 |
Loa Loa (eye worm) | proprotein convertase 2 | 0.0035 | 0.0398 | 0.0406 |
Echinococcus multilocularis | neuroendocrine convertase 2 | 0.0092 | 0.2979 | 0.6877 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0026 | 0 | 0.5 |
Brugia malayi | neuroendocrine convertase 1 precursor | 0.0092 | 0.2979 | 0.2979 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.2285 | 0.5029 |
Loa Loa (eye worm) | CBP-B | 0.0085 | 0.2668 | 0.2727 |
Echinococcus granulosus | CREB binding protein | 0.0122 | 0.4351 | 0.7865 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0089 | 0.2843 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.2285 | 0.2335 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0035 | 0.0398 | 0.1032 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2285 | 0.2705 |
Brugia malayi | endoprotease bli-4 precursor | 0.0146 | 0.5424 | 0.5424 |
Leishmania major | hypothetical protein, conserved | 0.0026 | 0 | 0.5 |
Brugia malayi | Nuclear hormone receptor-like 1 | 0.0243 | 0.9786 | 0.9786 |
Echinococcus multilocularis | CREB binding protein | 0.0084 | 0.262 | 0.5921 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.2285 | 0.2335 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0035 | 0.0398 | 0.1032 |
Echinococcus multilocularis | proprotein convertase subtilisin:kexin type 5 | 0.0089 | 0.2843 | 0.6515 |
Loa Loa (eye worm) | hypothetical protein | 0.0243 | 0.976 | 0.9974 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0026 | 0 | 0.5 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.2285 | 0.2335 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2285 | 0.2705 |
Brugia malayi | Nuclear hormone receptor-like 1 | 0.0243 | 0.9786 | 0.9786 |
Echinococcus granulosus | furin | 0.0146 | 0.5424 | 1 |
Trypanosoma brucei | RNA helicase, putative | 0.0207 | 0.8136 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0026 | 0 | 0.5 |
Echinococcus granulosus | neuroendocrine convertase 2 | 0.0092 | 0.2979 | 0.5135 |
Loa Loa (eye worm) | nuclear hormone receptor-like 1 | 0.0243 | 0.9786 | 1 |
Giardia lamblia | High cysteine membrane protein Group 2 | 0.0054 | 0.1289 | 1 |
Echinococcus multilocularis | 0.0118 | 0.4151 | 1 | |
Brugia malayi | proprotein convertase 2 | 0.0092 | 0.2979 | 0.2979 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2285 | 0.2705 |
Loa Loa (eye worm) | hypothetical protein | 0.0057 | 0.1425 | 0.1456 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0035 | 0.0398 | 0.1032 |
Loa Loa (eye worm) | endoprotease bli-4 | 0.0146 | 0.5424 | 0.5543 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0026 | 0 | 0.5 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0026 | 0 | 0.5 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0035 | 0.0398 | 0.1032 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2285 | 0.2705 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.2285 | 0.3755 |
Loa Loa (eye worm) | hypothetical protein | 0.0057 | 0.1429 | 0.146 |
Schistosoma mansoni | subfamily S8B unassigned peptidase (S08 family) | 0.0146 | 0.5424 | 0.6619 |
Loa Loa (eye worm) | hypothetical protein | 0.0146 | 0.5424 | 0.5543 |
Schistosoma mansoni | CREB-binding protein 2 | 0.0122 | 0.4351 | 0.528 |
Brugia malayi | RNA binding protein | 0.0076 | 0.2285 | 0.2285 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | 167.158 uM | PubChem BioAssay. Luminescence-based cell-based high throughput dose response assay to identify activators of Transthyretin (TTR) transcription. (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (functional) | 167.158 uM | PubChem BioAssay. Counterscreen for activators of Transthyretin (TTR) transcription: Luminescence-based cell-based high throughput dose response assay to identify inhibitors of Transthyretin (TTR) transcription in HuH7 hepatoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: Confirmation Concentration-Response Assay for Cell signaling CRE-BLA (Fsk stim) - HEK293 CREB Luciferase. (Class of assay: confirmatory) [Related pubchem assays: 662 ] | ChEMBL. | No reference |
Potency (functional) | 19.9526 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.